Dark Forest Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-103,674
Closed -$2.91M 982
2026
Q1
$2.91M Buy
+103,674
New +$2.76M 0.26% 95
2025
Q2
Sell
-54,674
Closed -$1.39M 1438
2025
Q1
$1.39M Buy
+54,674
New +$1.43M 0.06% 532
2024
Q4
Sell
-22,328
Closed -$646K 1222
2024
Q3
$646K Sell
22,328
-23,937
-52% -$698K 0.08% 290
2024
Q2
$1.29M Buy
+46,265
New +$1.27M 0.24% 73
2023
Q3
Sell
-30,867
Closed -$1.13M 1262
2023
Q2
$1.13M Buy
+30,867
New +$1.2M 0.1% 253
2023
Q1
Sell
-45
Closed -$2.31K 1409
2022
Q4
$2.31K Buy
+45
New +$2.16K ﹤0.01% 940
2022
Q3
Sell
-63
Closed -$3K 1369
2022
Q2
$3K Sell
63
-88
-58% -$4.48K ﹤0.01% 696
2022
Q1
$8K Buy
+151
New +$7.83K ﹤0.01% 1043
2021
Q4
Sell
-3,186
Closed -$137K 1701
2021
Q3
$137K Buy
3,186
+250
+9% +$11.1K 0.05% 308
2021
Q2
$115K Buy
+2,936
New +$114K 0.05% 294

Other funds holding PFE

Dark Forest Capital Management's PFE Position: Q2 2026 in Review

Dark Forest Capital Management sold out of Pfizer (PFE) in Q2 2026, closing a stake of 103,674 shares — an estimated $2.91M sold.

Dark Forest Capital Management first reported a position in PFE in Q2 2021 and held it in 10 quarters. The position peaked at $2.91M in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Dark Forest Capital Management reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Dark Forest Capital Management sold 103,674 Pfizer shares in Q2 2026, an estimated $2.91M.
  • Dark Forest Capital Management first reported a position in Pfizer in Q2 2021 and held it in 10 quarters.
  • Dark Forest Capital Management's Pfizer position peaked at $2.91M in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.